Hack Andrew A. F.

Average Profitability
28.87%
Insider Buys Quantity
20
Insider Buys Sum
$137.81M
Insider Sells Quantity
29
Insider Sells Sum
$250.02M

Insider Activity of Hack Andrew A. F.

According to the SEC Form 4 filings, Hack Andrew A. F., being in a position of

  1. director at Nuvalent, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 880000 shares for $64.04M,
    over all time since 2021-08-02, has bought 1768506 shares for $34.99M, and sold 880000 shares for $64.04M.

The largest purchase of all time was on 2020-04-07 and amounted to 6891334 shares of Mersana Therapeutics, Inc. for $41.3M.

The largest sale of all time was on 2024-03-27 and amounted to 880000 shares of Nuvalent, Inc. for $64.04M.

Biography of Hack Andrew A. F.

No biography is available at this moment.

2024-03-27SaleNuvalent, Inc.
NUVL
director
880,000
1.3042%
$72.77$64.04M+3.28%
2023-08-08SaleDynavax Technologies Corporation
DVAX
director
1.5M
1.1284%
$14.39$21.59M-11.69%
2023-06-14SaleDynavax Technologies Corporation
DVAX
director
500,000
0.3927%
$12.68$6.34M+6.26%
2023-05-18SaleDynavax Technologies Corporation
DVAX
director
1M
0.7525%
$10.55$10.55M+22.38%
2022-12-06SaleDynavax Technologies Corporation
DVAX
director
1.5M
1.4875%
$11.60$17.4M+1.85%
2022-11-03PurchaseNuvalent, Inc.
NUVL
director
298,506
0.6374%
$33.50$10M+32.21%
2022-08-15SaleDynavax Technologies Corporation
DVAX
3M
2.219%
$14.68$44.04M-27.66%
2022-05-31PurchaseMersana Therapeutics, Inc.
MRSN
14,760
0.0148%
$3.20$47,182+90.72%
2022-05-24PurchaseMersana Therapeutics, Inc.
MRSN
75,000
0.0765%
$3.19$238,943+88.96%
2022-05-23PurchaseMersana Therapeutics, Inc.
MRSN
director
15,599
0.0162%
$3.35$52,247+83.04%
2022-05-20PurchaseMersana Therapeutics, Inc.
MRSN
director
100,000
0.1034%
$3.46$345,570+75.07%
2022-05-19PurchaseMersana Therapeutics, Inc.
MRSN
115,599
0.1213%
$3.47$400,867+76.52%
2022-05-18PurchaseMersana Therapeutics, Inc.
MRSN
director
211,268
0.2245%
$3.35$707,262+84.19%
2022-05-17PurchaseMersana Therapeutics, Inc.
MRSN
director
3,440
0.0034%
$3.18$10,952+79.82%
2022-05-16PurchaseMersana Therapeutics, Inc.
MRSN
138,732
0.1441%
$3.10$430,398+93.91%
2022-04-13PurchaseMersana Therapeutics, Inc.
MRSN
1.23M
1.1527%
$4.05$5M+28.04%
2022-04-12PurchaseMersana Therapeutics, Inc.
MRSN
1.2M
1.3086%
$4.18$5M+45.36%
2022-02-07PurchaseMersana Therapeutics, Inc.
MRSN
director
2.27M
2.7929%
$4.42$10.05M+25.11%
2021-12-30PurchaseMersana Therapeutics, Inc.
MRSN
director
1.63M
2.2192%
$6.15$10.02M-17.11%
2021-12-29PurchaseMersana Therapeutics, Inc.
MRSN
director
1.75M
2.4751%
$5.75$10.06M-7.9%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.